High blood pressure is linked to a myocardial anatomical change called LVH. Learn how to offset left ventricular thickening ...

Another active area of research in the laboratory focuses on unraveling the mechanisms behind maladaptive, or pathological, and adaptive, or physiological, cardiac hypertrophy. In response to certain ...

In a groundbreaking study, the regulatory role of the long noncoding RNA (lncRNA) Gm20257 in pathological cardiac hypertrophy ...

You have full access to this article via your institution. Though activation of the calcineurin pathway can produce cardiac hypertrophy in transgenic mice 3, the results of our study indicate that ...

Aim Differentiating physiological cardiac hypertrophy from pathology is challenging when ... The ECG remains key and should guide follow-up management. Marked repolarisation changes, ST depression, ...

Kawasaki disease (KD), an acute self-limited febrile illness that primarily affects children <5 years old, is the leading cause of acquired heart disease in developed countries, with the potential of ...

The effectiveness of existing strategies for management of atrial fibrillation ... greatest benefit seen in patients with left ventricular (LV) hypertrophy and/or heart failure.

Primary care clinicians and practices are uniquely positioned to help people achieve optimal cardiovascular health through ...

For example, a blockers increase plasma volume, may increase plasma norepinephrine levels, and when left ventricular (LV) hypertrophy exists, they do not regress LV mass as well as diuretics.

Cardiovascular system Cardiac hypertrophy; increased stroke volume (SV); decrease in resting heart rate (HR); increase in maximum cardiac output (Q); capillarisation at the lungs and muscles ...

Over time, this increased workload can lead to hypertrophy, an enlargement of the heart muscle, making it less efficient ... ensures that interventions can be adjusted as needed. Stress Management: ...